发明名称 Aminothiazole inhibitors of cyclin dependent kinases
摘要 Compounds of the formulaand pharmaceutically acceptable salts thereof.R1 and R2 are independently hydrogen, fluorine or alkyl;R3 is aryl or heteroarylR4 is alkyl, cycloalkyl, aryl, cycloalkylalkyl, arylalkyl, heteroaryl, heteroarylalkyl, heterocycloalkyl, heterocycloalkylalkyl;m is an integer of 0 to 2; andn is an integer of 1 to 3.The compounds of formula I are protein kinase inhibitors and are useful in the treatment and prevention of proliferative diseases, for example, cancer, inflammation and arthritis. They may also be useful in the treatment of neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases.
申请公布号 AU2062701(A) 申请公布日期 2001.06.25
申请号 AU20010020627 申请日期 2000.12.06
申请人 BRISTOL-MYERS SQUIBB CO. 发明人 KYOUNG S. KIM;S. DAVID KIMBALL;ZHEN-WEI CAI;DAVID B. RAWLINS;RAJ N. MISRA;MICHAEL A. POSS;KEVIN R. WEBSTER;JOHN T. HUNT;WEN-CHING HAN
分类号 C07D277/20;A61K31/426;A61K31/427;A61K31/428;A61K31/433;A61K31/4439;A61K31/454;A61K31/4709;A61K31/4725;A61K31/497;A61K31/506;A61K45/00;A61P1/00;A61P1/04;A61P9/00;A61P9/10;A61P9/14;A61P17/02;A61P17/06;A61P19/02;A61P21/00;A61P25/00;A61P25/16;A61P25/28;A61P29/00;A61P31/10;A61P31/12;A61P31/18;A61P35/00;A61P35/04;A61P37/06;A61P43/00;C07D263/00;C07D277/00;C07D277/42;C07D277/44;C07D277/54;C07D417/12;C07D417/14;C07D521/00 主分类号 C07D277/20
代理机构 代理人
主权项
地址